Navigation Links
Docs Say No to Pulling Drugs Containing Acetaminophen off the Market
Date:7/20/2009

FLEMINGTON, N.J., July 20 /PRNewswire/ -- A new national media study among 589 physicians revealed that the majority of physicians (82%) do not believe that drugs containing acetaminophen should be pulled off the market.

(Logo:http://www.newscom.com/cgi-bin/prnh/20071204/NYTU133LOGO )

The study was conducted by HCD Research using its MediaCurves.com(R) website during July 17-19, to obtain physicians' perceptions of a CNN news clip which outlined an FDA committee's recent concern regarding acetaminophen, a drug found in several common prescription and non-prescription products. To view agreement curves and detailed results go to: www.mediacurves.com.

"Physicians expressed sharp disagreement when the CNN reporter stated: 'the committee said yank them off the market -- no more Vicodin, no more Percocet,' as evidenced by the downward spiral of our automated response curves," explained Glenn Kessler, president and CEO, HCD Research.

The majority of doctors (70%) reported that the FDA's warnings and concerns regarding the acetaminophen have not affected their prescribing habits.

Among the findings:

"Have your prescribing habits changed since becoming aware of the FDA's recent warnings and concerns regarding the drug Acetaminophen? Select all that apply."

                                                         Total
                                                        (n=589)
                                                         ------
    More likely to prescribe products containing
     Acetaminophen                                          1%

    Less likely to prescribe products containing
     Acetaminophen                                          8%

    More likely to discuss warnings and dosage
     instructions with patients who are prescribed
     or use Acetaminophen products                         29%

    No change in prescribing habits for products
     containing Acetaminophen                              70%

    Other                                                   1%



"Do you think the FDA should pull Acetaminophen products?"

                                                         Total
                                                        (n=589)
                                                         ------
    Yes, both prescription and non-prescription
     Acetaminophen products                                 4%

    Yes, prescription Acetaminophen products only           6%

    Yes, non-prescription Acetaminophen products
     only                                                   3%

    Yes, they should pull only certain products
     containing Acetaminophen.                              6%

    No, they should not pull any Acetaminophen
     products                                              82%



While viewing the video, participants indicated their levels of agreement by moving their mouse from left to right on a continuum. The responses were recorded in quarter-second intervals and reported in the form of curves. The participants were also asked to respond to post-viewing questions.

HCD Research is a marketing and communications research company headquartered in Flemington, NJ. For additional information on HCD Research, access the company's website at www.hcdi.net. MediaCurves.com(R) (www.mediacurves.com) is a media measurement website that provides the media and general public with a venue to view Americans' perceptions of popular and controversial media events and advertisements.


'/>"/>
SOURCE HCD Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging
2. High-Salt Diet Dampens Effects of Blood Pressure Drugs
3. Debate Over Advertising Prescription Drugs to Consumers Goes Online at New ProCon.org Website
4. Crime, Drugs and Health Problems Face Vancouvers Downtown Eastside
5. CMPI to Host Hill Briefing Tomorrow on Follow-on Biologic Drugs for Media and Congressional Staff With Reps. Eshoo and Rogers
6. China Nepstar Chain Drugstore Acquires Drugstores in Beijing
7. The National Council on Aging and CVS/pharmacy Educate Tampa Seniors on Medication Management and How to Save Money on Prescription Drugs
8. Dry mouth linked to prescription and over the counter drugs
9. CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers
10. Post-transplant combo can replace toxic immune-suppressing drugs in monkeys
11. New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management Association ... marketing programs at the annual Building Better Radiology Marketing Programs conference, held ... in Fort Worth, Texas. Nine awards are given out in five categories. They are:, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... first two episodes of WE TV’s “Mama June: From Not to Hot,” which will ... TV notable, “Mama” June Shannon, known to millions from the 2012 reality television series, ...
(Date:2/23/2017)... ... ... Dr. David Mahon leads Siena Dental, a comprehensive dental practice located at ... Top Patient Rated Henderson Dentist by Find Local Doctors earlier this year. ... dentists who have earned high ratings and superior patient reviews from multiple credible sources. ...
(Date:2/23/2017)... ... 2017 , ... The Center for Autism and Related Disorders ... Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The events ... films in an environment that accommodates their unique needs. , Launched in January, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... SEOUL , Südkorea, 23. Februar 2017 ... LED für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache ... kurzwellige ultraviolette Strahlung im Bereich zwischen 200 und 280 nm ... Ausbreitung von Bakterien, indem es ihre DNA zerstört. Das ... 280 nm. ...
(Date:2/23/2017)... , 23. Februar 2017 Im Rahmen ... nationale Wirtschaftszone in der südwestlichen chinesischen Provinz Guizhou, 2017 mit ... einer Innovationsplattform aktiv an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. ... Continue Reading ... ...
Breaking Medicine Technology: